Cargando…
Combination Treatment of Topical Imiquimod Plus Anti-PD-1 Antibody Exerts Significantly Potent Antitumor Effect
SIMPLE SUMMARY: Imiquimod (IMQ), a synthetic ligand of Toll-like receptor 7, is known to exert antitumor effects. However, the exact mechanisms of the IMQ-induced antitumor effect have not been fully understood. Although both topical IMQ treatment and anti-PD-1 antibody may be used for primary skin...
Autores principales: | Oya, Kazumasa, Nakamura, Yoshiyuki, Zhenjie, Zhu, Tanaka, Ryota, Okiyama, Naoko, Ichimura, Yuki, Ishitsuka, Yosuke, Saito, Akimasa, Kubota, Noriko, Watanabe, Rei, Tahara, Hideaki, Fujimoto, Manabu, Fujisawa, Yasuhiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391905/ https://www.ncbi.nlm.nih.gov/pubmed/34439104 http://dx.doi.org/10.3390/cancers13163948 |
Ejemplares similares
-
Eribulin mesylate exerts antitumor effects via CD103
por: Oya, Kazumasa, et al.
Publicado: (2023) -
Poor Lymphocyte Infiltration to Primary Tumors in Acral Lentiginous Melanoma and Mucosal Melanoma Compared to Cutaneous Melanoma
por: Nakamura, Yoshiyuki, et al.
Publicado: (2020) -
Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6
por: Tanaka, Ryota, et al.
Publicado: (2020) -
Honey and Chamomile Activate Keratinocyte Antioxidative Responses via the KEAP1/NRF2 System
por: Ogawa, Tatsuya, et al.
Publicado: (2020) -
PD-1 Regulates Passive Anaphylaxis: A Possible Role of the Mast Cell Intracellular Inhibitory Signal
por: Ogawa, Tatsuya, et al.
Publicado: (2021)